Find Academic Supervisors

• Breast Cancer Screening
• Epidemiology
• Public Health
• +4 more

Dr. Naomi Noguchi is a Senior Lecturer and Course Coordinator in Clinical Epidemiology at the Sydney School of Public Health, University of Sydney. Her research focuses on breast cancer screening, geriatric syndromes, urinary health in aging populations, and the application of artificial intelligence in medical imaging. She has contributed to major studies on risk stratification in breast cancer screening, frailty assessment in surgical patients, and longitudinal analysis of aging-related health conditions such as urinary dysfunction. Notable research includes systematic reviews on breast cancer risk factors, comparative studies of digital breast tomosynthesis versus mammography, and the Concord Health and Ageing in Men Project. Her work bridges clinical epidemiology with public health policy, emphasizing evidence-based approaches to healthcare for older adults. Dr. Noguchi has been involved in grants evaluating digital imaging technologies and their impact on screening outcomes, as well as projects assessing risk scores for vascular surgery outcomes in elderly patients. She has published extensively in journals like British Journal of Cancer , Breast , and Medical Journal of Australia , with a focus on translating epidemiological findings into clinical practice. Her research also explores disparities in healthcare outcomes for ethnic minority groups and the implications of AI-driven diagnostic tools in screening programs.

Chen-Han Wilfred WuView profile

Assistant Professor

• Genomics
• Human Genetics
• Urology
• +7 more

Dr. Chen-Han Wilfred Wu is an Assistant Professor at the Department of Genetics and Genome Sciences and Urology , Case Western Reserve University School of Medicine . He serves as the Director of the Urogenetics Program and is a member of the Cancer Genomics and Epigenomics Program at the Case Comprehensive Cancer Center. Dr. Wu's work bridges clinical urology and genetic research, focusing on genomics in urological diseases. Education: MD, National Taiwan University, Taipei, Taiwan PhD, Human Genetics, University of Utah Clinical Genetics and Biochemical Genetics Training, Harvard Medical School Dr. Wu's research explores the genomic basis of urological conditions , including kidney stones, male infertility, transgender biology, genitourinary cancers, congenital kidney anomalies, and voiding dysfunction. His lab integrates electronic medical records (EMR) with genomic sequencing from resources like the UK Biobank and All-of-Us, combining dry and wet lab approaches. His recent publications highlight trends in congenital kidney anomalies (ARHGEF6, ZMYM2, FOXC1 variants), urological cancers (upper tract urothelial carcinoma), metabolic disorders (cystine stones, calcium oxalate nephrolithiasis), and systemic implications of monogenic kidney diseases. Key methodologies include exome sequencing , gene network analysis , and cross-species modeling . Dr. Wu's lab collaborates with the Urology Institute at University Hospitals and the Department of Genetics and Genome Sciences . He mentors trainees in bedside-to-bench research , leveraging both phenotypic data and multi-omics analysis to advance precision medicine in urology.

Casey G. KowalikView profile

Associate Professor

• Female Pelvic Medicine and Reconstructive Surgery
• clinical outcomes research
• neurogenic bladder
• +3 more

Casey G. Kowalik, M.D., FACS is an Associate Professor in the Department of Urology at the University of Kansas School of Medicine, specializing in Female Pelvic Medicine and Reconstructive Surgery since August 2018. His clinical expertise focuses on complex pelvic floor disorders and reconstructive urologic surgery. Dr. Kowalik's educational background includes: MD in Medicine from the University of Virginia School of Medicine (2010) General Surgery Internship at Lahey Hospital & Medical Center, Burlington, MA Urology Residency at Lahey Hospital & Medical Center, Burlington, MA Clinical Fellowship in Female Pelvic Medicine & Reconstructive Surgery at Vanderbilt University Medical Center, Nashville, TN His research program centers on clinical outcomes for neurogenic bladder and urinary incontinence patients, with particular emphasis on regenerative medicine approaches. As Site Principal Investigator for the NIH-funded CELLEBRATE trial, he leads research on autologous muscle-derived cell therapy for stress urinary incontinence. His work integrates epidemiological, behavioral, and surgical perspectives to address gaps in pelvic floor disorder management across diverse patient populations. Analysis of Dr. Kowalik's 2017-2020 publications reveals consistent focus on urinary incontinence mechanisms and treatment barriers, with emerging themes in environmental determinants of bladder health and frailty impacts on surgical outcomes. His collaborative studies frequently examine understudied populations including young nulligravid women and neurogenic bladder patients. Professional recognition includes: Fellow of the American College of Surgeons (FACS) Dr. Kowalik maintains active grant funding through the NIH-sponsored CELLEBRATE trial while mentoring junior researchers in clinical urology investigations. His current projects examine nonclinical barriers to pelvic floor care and digital health interventions for bladder symptom management. Within the University of Kansas Medical Center ecosystem, he collaborates with multidisciplinary teams across urology, gynecology, and geriatrics to advance pelvic floor disorder research and clinical protocols.

• Urology
• Prostate Cancer
• Urinary Tract Obstruction
• +3 more

Şahin Paşalı is a Doctor Lecturer at Kastamonu Üniversitesi, Faculty of Medicine, Department of Surgical Medical Sciences. He has been employed since 2021 as a full-time academic staff member. Education: Bachelor's Degree from Ankara University (Faculty of Medicine, Department of Medicine, 2005-2012) Medical Specialization: Ankara Numune Training and Research Hospital (2013-2019) His research focuses on urological conditions, surgical complications, and pediatric urology. Key areas include prostate surgery, urinary tract obstructions, and diagnostic imaging techniques. Recent publications highlight case studies on rare urological anomalies, surgical outcomes, and anesthesia methods in prostate diagnostics. His work spans clinical research, surgical pathology, and evidence-based urology. Collaborations include Cüneyt Özden (2019-2021), Cevdet Serkan Gökkaya (2019-2021), and Rıdvan Özbek (2023-2024). He has co-authored 7 articles, 3 book chapters, and contributed to international publications.

Joshua CohnView profile

Associate Professor

• Urology
• Urologic Oncology
• Reconstructive Surgery
• +6 more

Joshua Cohn is an Associate Professor in Urology at Temple University, affiliated with the Fox Chase Cancer Center. He specializes in urologic oncology, neuro-urology, and reconstructive surgery for urinary disorders. Education & Credentials MD – University of Michigan, Ann Arbor Fellowship – Female Pelvic Medicine and Reconstruction, Vanderbilt University Medical Center Residency – University of Chicago Certified by American Board of Urology Research Trends His research focuses on urinary incontinence, pelvic organ prolapse, robotic surgery, and health literacy. Key themes include minimally invasive techniques, cancer survivorship, and neurologic causes of bladder dysfunction. Scientific Awards Chicago Urologic Society First Prize (2014) SUDM Resident Travel Award (2014) CURE Travel Scholarship (2015) Hans Marberger Award, European Urology Association (2016) AUA Best Poster (2017) Philadelphia Magazine Top Doctors (2024)

Gary LemackView profile

Professor

• Urology
• Neurology
• Urinary Incontinence
• +7 more

Dr. Gary Lemack is a tenured Professor in the Department of Urology at UT Southwestern Medical Center, with a secondary appointment in Neurology. He specializes in urinary incontinence, pelvic organ prolapse, overactive bladder, and voiding dysfunction in neurological diseases, particularly spinal cord injury, multiple sclerosis, and Parkinson’s Disease. He has served as Residency Program Director since 2004 and previously led the Female Pelvic Medicine and Reconstructive Surgery Fellowship. Education: Medical degree from Cornell University, residency at The New York Hospital, and fellowship training in neurourology at UT Southwestern. His research focuses on urodynamics for lower urinary tract dysfunction, best practices for neurological bladder conditions, and reconstructive pelvic surgery. He has authored 3 AUA guidelines and over 160 original articles. Notable awards include the Paul Zimskind and Distinguished Service awards from SUFU, Texas Monthly Super Doctor, and D Magazine Best Doctor. He has held leadership roles in SUFU (Past President, Executive Committee 2005-2020), American Board of Urology (Past President), and the Journal of Urology Editorial Board.

• Biochemistry
• Microbiology
• Immunology
• +2 more

Stanley Moore is an Associate Professor in the Department of Biochemistry at the University of Saskatchewan , with research interests spanning Biochemistry , Microbiology , Immunology , and Structural Biology . Prior to joining Saskatchewan in 2002, he held a Lecturer position at Massey University (1994-1998). His academic journey includes a PhD in Structural Biology (University of Alberta, 1994) and a B.Sc. Honours in Chemistry (Dalhousie University, 1986). Moore’s research focuses on two primary areas: Flagellum secretion systems in Helicobacter pylori , a gastric pathogen, and Chromatin modifying systems in higher eukaryotes, particularly their structural and functional dynamics. His recent publications highlight work in protein crystallography (2019), PTEN-p85α signaling interactions (2018), and mitochondrial copper transport mechanisms (2021), reflecting interdisciplinary applications of structural biology to microbial and human systems. Key collaborative projects include clinical studies on urological trauma outcomes (2023) and sepsis survivor follow-up (2019), though these appear to involve co-authorship rather than primary authorship. Notably, Moore’s personal interests include black licorice cigars —a recreational choice he humorously clarifies is not an endorsement of smoking.

William F. Collins, IIIView profile

Associate Professor

• Neurophysiology
• Motor Neuron Function
• Neuronal Plasticity
• +3 more

William F. Collins, III is an Associate Professor in the Department of Neurobiology & Behavior at Stony Brook University, affiliated with the Renaissance School of Medicine. He holds a PhD from the University of Pennsylvania and has held academic roles including Research Assistant Professor and Visiting Assistant Professor prior to his current tenure-track position since 1996. He served as Director of the Undergraduate Biology Program (1998–2004) and Director of the Freshman Learning Communities Program (2004–2007). Dr. Collins' research focuses on the intrinsic properties of motoneurons and their role in motor function, particularly addressing spinal cord injury-induced bladder-sphincter dyssynergia. His work combines electrophysiological techniques in rodent models to study neuronal plasticity, neurotransmitter effects, and injury responses. Awards include the Chancellor's and President's Excellence in Teaching Award (1997) and recognition as a National Academies Education Fellow in the Life Sciences (2004). His laboratory is located in the Life Sciences Building (Office 534, Lab 525). Education: B.A. Biophysics (1974), PhD Pharmacology (1980), both from University of Pennsylvania Postdoctoral Training: SUNY Stony Brook Neurophysiology (1983) Professional Affiliations: SUNY Stony Brook (1985–present), Yale University (1984–1985)

Caleb NelsonView profile

Clinical Professor

• Pediatric Urology
• Health Services Research
• Kidney Stones
• +3 more

Caleb Nelson is a Clinical Professor at Harvard Medical School and an attending pediatric urologist at Boston Children’s Hospital. His research focuses on improving evidence-based practices in pediatric urology, health services delivery, and clinical outcomes for conditions like vesicoureteral reflux (VUR), kidney stones, and hydronephrosis. He leads the NIH-funded RIVUR study, a multicenter trial evaluating antibiotic prophylaxis in children with VUR, and holds an NIH K23 award for studying outcomes in siblings of children with VUR. Education: B.A. from Dartmouth College (1992), M.D. from Duke University (1997), and an M.P.H. in epidemiology from the University of Michigan (2003). Completed residency in urology at the University of Michigan (2002), followed by a pediatric urology fellowship at Johns Hopkins (2006). He also completed an NIH-funded clinical research fellowship. Research interests include optimizing imaging practices, antibiotic use patterns, and leveraging artificial intelligence (AI) in pediatric urology through the AI-PEDURO collaborative. His work addresses disparities in care, telemedicine efficacy, and quality improvement in urological practices. Publications (2020–2025) emphasize advancements in pediatric urology, including AI applications, antibiotic stewardship, and clinical trial methodologies. Key themes include reducing practice variation, improving diagnostic accuracy, and enhancing patient safety. Awards: NIH K23 Career Development Award (NIDDK). Grants: RIVUR study (NIH-funded), K23 award, and multiple institutional grants. Labs/Teams: Lead the AI-PEDURO initiative and collaborate on national research networks like the Pediatric Kidney Stone Care Improvement Network.

Scott BauerView profile

Associate Professor

• Geriatric Urology
• Aging Mechanisms
• Biomarkers in Aging
• +4 more

Dr. Scott Bauer is an Associate Professor of Medicine at the University of California, San Francisco (UCSF) , affiliated with the School of Medicine . He is a general internist, translational epidemiologist, and clinician investigator based at the San Francisco Veterans Affairs Medical Center (SFVAMC). His research focuses on understanding mechanisms of urologic aging and defining clinical phenotypes/biomarkers for older adults with debilitating urologic conditions. Key affiliations include the Baker Aging Research Institute , the Kidney Health Research Collective , and the Women's Health Clinical Research Center . Education: Sc.M. in Epidemiology, Harvard School of Public Health (2011) M.D., University of California, San Francisco (2015) Internal Medicine Residency, UCSF (2018) DEI Champion Training, UC System (2019) Research Interests: Dr. Bauer specializes in geriatric urology , investigating lifestyle/age-related risk factors, biomarkers, and functional outcomes. His work bridges urologic conditions (e.g., overactive bladder, benign prostatic hyperplasia) with aging mechanisms like mitochondrial dysfunction, frailty, and muscle health. He leads studies on exercise interventions (e.g., the PROUD trial) and mobile health technologies for symptom management. Grants & Funding: NIH R01DK135804 (2023–2026) – Exercise for Urinary Symptoms in Older Men NIH K76AG074903 (2021–2026) – Muscle Health and Urinary Symptoms NIH R03AG067937 (2020–2022) – Frailty and Lower Urinary Tract Symptoms Awards: Health in Aging Foundation New Investigator Award (2021) Grunfeld Scholar (2020) Best Abstract Award, Claude D Pepper OAIC (2020) Labs/Teams: Leads the Geriatric Urology and Aging Urinary System Lab at UCSF, focusing on translational research to improve care for older adults with urologic conditions. Collaborates with the PROUD Study on exercise interventions and the Study of Muscle, Mobility, and Aging (SOMMA) on frailty biomarkers.

Guiming LiuView profile

Associate Professor

• Lower Urinary Tract Dysfunction
• Obesity and Diabetes Complications
• Urology Research
• +4 more

Dr. Guiming Liu is an Associate Professor in the Department of Anatomy and Neurobiology at Northeast Ohio Medical University (NEOMED). He holds a Ph.D. from China Medical University (2002) and has held academic positions at institutions including MetroHealth Medical Center (CWRU), The Cleveland Clinic, and SUNY Upstate Medical University. His research focuses on urinary tract dysfunction, obesity-diabetes interplay, and translational therapies. He serves on editorial boards for journals like Advances in Medicine and Frontiers in Surgery . Education: Ph.D. in Biomedical Sciences, China Medical University, 2002. Postdoctoral training at The Cleveland Clinic (2002–2005). Research Interests: Investigating pathogenesis of bladder dysfunction in metabolic disorders, mechanisms of urological complications in diabetes/obesity, and developing novel treatments for gastrointestinal injury. Publications span over 50 peer-reviewed articles, emphasizing mechanisms of diabetic bladder dysfunction, obesity-induced urinary symptoms, and stem cell-based therapies. Key grants include NIH R01 and ADA awards for urinary incontinence and diabetes research. Awards: JDRF Postdoctoral Fellowship (2005–2007), ADA Junior Faculty Award (2010–2013) Grants: NIH NIDDK R01 DK110567 (Co-PI), NIH U24 DK076169 (Subaward PI) His work bridges basic science and clinical applications, with a focus on translational research for urological disorders.

Margot DamaserView profile

Professor

• Regenerative Medicine
• Tissue Engineering
• Biomechanics
• +7 more

Margot Damaser, PhD is a Senior Rehabilitation Career Scientist at the Louis Stokes Cleveland VA and Principal Investigator of the Urological Biomechanics Laboratory at Cleveland Clinic's Main Campus. Her research program bridges biomedical engineering and clinical urology to develop innovative treatments for pelvic floor disorders. Dr. Damaser's research focuses on regenerative medicine, tissue engineering, and device development for pelvic floor dysfunction including urinary and fecal incontinence and pelvic organ prolapse. Her laboratory has developed wireless catheter-free monitoring devices for bladder and colon function, and conducts studies on regenerating damaged pelvic tissue using stem cells, electrical stimulation, and elastogenic nanoparticles. Her work combines engineering principles with clinical applications to translate research into practical diagnostic and therapeutic solutions. Dr. Damaser's publication record shows a strong focus on understanding the neural control of bladder function and developing closed-loop neuromodulation systems. Her recent work has explored brain-derived neurotrophic factors, pudendal nerve regeneration, and stem cell therapies for stress urinary incontinence. She has also contributed significantly to ambulatory urodynamics with wireless monitoring technologies that enable long-term physiological data collection. US Patent 10,537,274: Standardized measurement of physiological pressures using an air-charged catheter apparatus (2020) Dr. Damaser collaborates extensively with researchers across multiple institutions and has published in high-impact journals including Nature Reviews Urology, American Journal of Physiology, and Neurourology and Urodynamics. Her laboratory's work has implications for improving diagnosis and treatment of common pelvic floor disorders that significantly impact quality of life, particularly among elderly populations.

Kenneth M PetersView profile

Professor

• Voiding Dysfunction
• Female Urology
• Neuromodulation
• +3 more

Kenneth M Peters, MD is a Professor and Chair of Urology at the William Beaumont School of Medicine, Oakland University . He specializes in voiding dysfunction and female urology, with a focus on innovative treatments via neuromodulation and stem cell therapy. Education: Case Western Reserve University School of Medicine Residency/Fellowship: Beaumont Hospital Research interests include: Neuromodulation for voiding dysfunction Lumbar-to-sacral nerve re-routing in spina bifida patients Adult human stem cell applications for urinary incontinence Professional memberships: American Urological Association North Central Section of the AUA Society for Urodynamics & Female Urology Michigan Urological Society International Continence Society Research Council of the American Urological Association Awards: Clinical Research Award (twice)

Philippe ZimmernView profile

Professor

• Female Urology
• Pelvic Floor Disorders
• Urinary Incontinence
• +7 more

Philippe Zimmern, M.D. is a Professor of Urology at UT Southwestern Medical Center, holding the Felecia and John Cain Chair for Women's Health in Urology. He joined the faculty at UT Southwestern in 1995 after completing his medical training at Necker-Enfants Malades Hospital in Paris, France, and a fellowship at UCLA. Dr. Zimmern directs the female pelvic medicine and reconstructive surgery (FPMRS) fellowship program at UT Southwestern in collaboration with Gary Lemack, M.D., and Maude Carmel, M.D. Dr. Zimmern's clinical specialties include: Incontinence and prolapse Voiding dysfunction and urodynamics Fistula and urethral diverticulum repairs Mesh implant complications Urinary tract infections Vaginal surgery with native tissue repair Minimally invasive robotic surgery for prolapse His research focuses on female pelvic medicine, reconstructive surgery, and recurrent urinary tract infections. Through the Cure Recurrent Cystitis Initiative (CRCI) with Dr. Nicole De Nisco, he investigates the role of the urinary microbiome and inflammation in recurrent UTI pathology, aiming to develop anti-inflammatory and probiotic therapies. Dr. Zimmern has co-authored more than 365 publications, 28 surgical movies, and 65 book chapters, and co-edited four textbooks. His recent work (2024-2025) shows a clear trend toward innovative approaches to urinary incontinence and recurrent UTIs, with increasing focus on biotechnology applications, microbiome research, and novel device development. His publications span urology, gynecology, microbiology, and biomedical engineering, reflecting his interdisciplinary approach to women's urological health. Among his numerous honors and awards: 1997 Paul Zimskind Urodynamic Society Award Jane and John Justin Distinguished Chair in Urology (2005) SUFU Distinguished Service Award (2011) Continence Care Champion award from NAFC (2012) Inaugural Leaders in Excellence Award at UT Southwestern (2019) Felecia and John Cain Chair for Women's Health in Urology Dr. Zimmern has been a visiting professor internationally and serves on editorial boards for multiple urology journals. He is FPMRS certified and a member of FACS. He has directed the CRCI clinical studies investigating urinary microbiome changes over time in women with and without UTIs, aiming to identify beneficial bacteria for alternate UTI therapies. He leads the De Nisco-Zimmern Lab, which focuses on understanding the mechanisms behind recurrent urinary tract infections and developing novel treatments beyond antibiotics.

• Medical Biochemistry
• Obesity Research
• Oxidative Stress Mechanisms
• +4 more

Professor HİKMET KOÇAK serves as a full Professor in the Department of Biochemistry at Istinye University Faculty of Medicine, bringing over 15 years of academic experience following his promotion to full professorship in 2012. His career spans both Istanbul University (where he completed doctoral studies and served as Associate Professor from 2006-2012) and his current position at Istinye University. His research program focuses on medical biochemistry with specialization in obesity-related metabolic disorders , hepatic pathophysiology , and nutritional interventions . Professor Koçak's laboratory investigates molecular mechanisms through which dietary compounds like curcumin and capsaicin modulate oxidative stress, inflammation, and fat metabolism using rodent models and human clinical samples. Analysis of his recent publications reveals consistent emphasis on: Dietary polyphenol effects on liver fat accumulation Fetuin-A as a biomarker in metabolic syndrome Oxidative stress pathways in obesity Pathology education methodology His scientific recognition includes: Congress Award (2014) International Participation Congress Lab Expo (2013) 18th National Biochemistry Congress award (2004) Professor Koçak actively contributes to medical education through innovative pathology teaching methods and maintains clinical connections through biomarker research in obesity and metabolic disorders. His research program demonstrates strong translational potential for developing nutritional approaches to combat obesity-related complications.